1. Home
  2. TECX vs GENC Comparison

TECX vs GENC Comparison

Compare TECX & GENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECX
  • GENC
  • Stock Information
  • Founded
  • TECX 2019
  • GENC 1894
  • Country
  • TECX United States
  • GENC United States
  • Employees
  • TECX N/A
  • GENC N/A
  • Industry
  • TECX
  • GENC Construction/Ag Equipment/Trucks
  • Sector
  • TECX
  • GENC Industrials
  • Exchange
  • TECX Nasdaq
  • GENC Nasdaq
  • Market Cap
  • TECX 334.4M
  • GENC 215.0M
  • IPO Year
  • TECX 2018
  • GENC N/A
  • Fundamental
  • Price
  • TECX $22.19
  • GENC $15.06
  • Analyst Decision
  • TECX Buy
  • GENC
  • Analyst Count
  • TECX 5
  • GENC 0
  • Target Price
  • TECX $79.20
  • GENC N/A
  • AVG Volume (30 Days)
  • TECX 249.3K
  • GENC 27.8K
  • Earning Date
  • TECX 08-13-2025
  • GENC 08-08-2025
  • Dividend Yield
  • TECX N/A
  • GENC N/A
  • EPS Growth
  • TECX N/A
  • GENC N/A
  • EPS
  • TECX N/A
  • GENC 0.99
  • Revenue
  • TECX N/A
  • GENC $113,166,000.00
  • Revenue This Year
  • TECX N/A
  • GENC N/A
  • Revenue Next Year
  • TECX N/A
  • GENC N/A
  • P/E Ratio
  • TECX N/A
  • GENC $15.34
  • Revenue Growth
  • TECX N/A
  • GENC 7.70
  • 52 Week Low
  • TECX $13.70
  • GENC $10.80
  • 52 Week High
  • TECX $61.07
  • GENC $24.88
  • Technical
  • Relative Strength Index (RSI)
  • TECX 54.15
  • GENC 58.37
  • Support Level
  • TECX $20.39
  • GENC $14.72
  • Resistance Level
  • TECX $22.01
  • GENC $15.17
  • Average True Range (ATR)
  • TECX 1.18
  • GENC 0.68
  • MACD
  • TECX 0.15
  • GENC 0.03
  • Stochastic Oscillator
  • TECX 92.82
  • GENC 86.62

About TECX Tectonic Therapeutic Inc. Common Stock

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About GENC Gencor Industries Inc.

Gencor Industries Inc and its subsidiaries is a manufacturer of heavy machinery used in the production of highway construction materials and environmental control equipment. The Company has one reporting segment, equipment for the highway construction industry. The firm's principal products include asphalt plants, combustion systems, hot mix asphalt plants, fluid heat transfer systems, and asphalt pavers.

Share on Social Networks: